EA200500326A1 - Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента - Google Patents

Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента

Info

Publication number
EA200500326A1
EA200500326A1 EA200500326A EA200500326A EA200500326A1 EA 200500326 A1 EA200500326 A1 EA 200500326A1 EA 200500326 A EA200500326 A EA 200500326A EA 200500326 A EA200500326 A EA 200500326A EA 200500326 A1 EA200500326 A1 EA 200500326A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inflammatory agent
application
fermented extract
wheat spirits
avemar
Prior art date
Application number
EA200500326A
Other languages
English (en)
Other versions
EA007844B1 (ru
Inventor
Мате Хидвеги
Акош Решетар
Original Assignee
Мате Хидвеги
Акош Решетар
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мате Хидвеги, Акош Решетар filed Critical Мате Хидвеги
Publication of EA200500326A1 publication Critical patent/EA200500326A1/ru
Publication of EA007844B1 publication Critical patent/EA007844B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к новому применению ферментированного экстракта проростков пшеницы под товарным наименованием Avemar, более конкретно, к применению Avemarдля изготовления лекарственного средства, пригодного в качестве противовоспалительного агента для профилактики или лечения или облегчения воспалительных состояний, особенно артрита.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500326A 2002-08-09 2003-08-08 Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента EA007844B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0202638A HUP0202638A3 (en) 2002-08-09 2002-08-09 Use of fermented wheat-germ extract for preparation of antiphlogistic compositions
PCT/HU2003/000065 WO2004014406A1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent

Publications (2)

Publication Number Publication Date
EA200500326A1 true EA200500326A1 (ru) 2005-06-30
EA007844B1 EA007844B1 (ru) 2007-02-27

Family

ID=89980690

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500326A EA007844B1 (ru) 2002-08-09 2003-08-08 Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента

Country Status (15)

Country Link
EP (1) EP1536809A1 (ru)
JP (1) JP2006501214A (ru)
KR (1) KR20050059066A (ru)
CN (1) CN1674924A (ru)
AU (1) AU2003255854A1 (ru)
BR (1) BR0313589A (ru)
CA (1) CA2494744A1 (ru)
EA (1) EA007844B1 (ru)
HR (1) HRP20050114A2 (ru)
HU (1) HUP0202638A3 (ru)
IL (1) IL166732A0 (ru)
MX (1) MXPA05001469A (ru)
NO (1) NO20051168L (ru)
PL (1) PL375391A1 (ru)
WO (1) WO2004014406A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908998A1 (fr) * 2006-11-24 2008-05-30 Bao Quoc Ho Nouveau produit enzymatique et son utilisation.
HUP0900614A2 (en) 2009-09-29 2011-05-30 Mate Dr Hidvegi Preparation comprising dehydrated, fermented material with amorphous crystaline structure and process for its production
US9480725B2 (en) 2009-05-20 2016-11-01 The Regents Of The University Of California Fermented wheat germ proteins (FWGP) for the treatment of cancer
US20120164132A1 (en) * 2010-08-02 2012-06-28 Mate Hidvegi Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
GB201108560D0 (en) 2011-05-20 2011-07-06 3 Ch Ltd Use of fermented wheat germ in the treatment of inflammatory bowel disease
GB201110746D0 (en) 2011-06-23 2011-08-10 Biropharma Uk Ltd Wheat germ derived material
JP6115995B2 (ja) * 2013-04-24 2017-04-19 株式会社日清製粉グループ本社 非酵素的糖化反応抑制剤
CN104381450A (zh) * 2014-10-15 2015-03-04 张士远 治疗胃粘膜损伤的保健牛奶及其制备方法
WO2017196048A1 (ko) * 2016-05-11 2017-11-16 씨제이제일제당 (주) 밀배아 발효물의 추출물을 유효성분으로 함유하는 피부 주름 개선 외용제 조성물
KR101955111B1 (ko) * 2016-09-23 2019-03-07 씨제이제일제당 (주) 밀배아 발효물의 추출물을 유효성분으로 함유하는 피부진정 외용제 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242537A (ja) * 1994-03-04 1995-09-19 Kibun Foods Inc 抗炎症活性物質の製造方法および抗炎症剤
JPH08337536A (ja) * 1995-06-14 1996-12-24 Asahi Breweries Ltd 抗活性酸素作用剤並びにこれを有効成分とする抗活性酸素剤、化粧料、食品及び医薬品
HU223344B1 (hu) * 1997-08-13 2004-06-28 Máté Hidvégi Immunstimuláns és metasztázist gátló fermentált, szárított anyag, ezt tartalmazó gyógyszerkészítmények, eljárás az előállítására és alkalmazásai

Also Published As

Publication number Publication date
EA007844B1 (ru) 2007-02-27
HUP0202638A2 (hu) 2004-06-28
JP2006501214A (ja) 2006-01-12
HUP0202638A3 (en) 2007-08-28
AU2003255854A1 (en) 2004-02-25
CA2494744A1 (en) 2004-02-19
EP1536809A1 (en) 2005-06-08
IL166732A0 (en) 2006-01-15
PL375391A1 (en) 2005-11-28
MXPA05001469A (es) 2005-06-06
BR0313589A (pt) 2005-07-12
HU0202638D0 (ru) 2002-10-28
CN1674924A (zh) 2005-09-28
NO20051168L (no) 2005-03-04
KR20050059066A (ko) 2005-06-17
HRP20050114A2 (en) 2005-10-31
WO2004014406A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
IL172773A (en) Formulations for the treatment of arthritis conditions
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2007044084A3 (en) Heterocyclic inhibitors of mek and methods of use thereof
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
ECSP055844A (es) Nuevos compuestos triciclicos
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
NO20051168L (no) Anvendelse av fermentert hvetekimekstrakt som anti-inflammasjonsmiddel
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
PA8661701A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
UY28313A1 (es) Nonadepsipeptidos acilados
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO2007019078A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
ATE524463T1 (de) 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200503703A (en) Pharmaceutical compositions
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
WO2007019080A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
EP1597234A4 (en) NEW COMPOUNDS
WO2005107464A3 (en) Compounds and compositions as cathepsin s inhibitors

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU